2026. De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery. Journal of Cancer Research Updates. 15, 3 (Aug. 2026), 249–261. DOI:https://doi.org/10.30683/1929-2279.2026.15.23.